Back to products
Anti-Diabetic
- All products
- Hepatitis B Virus28 products
Bladder Cancer39 products
Breast Cancer38 products
- Colorectal Cancer28 products
Diabetic25 products
- Endometrial Cancer29 products
- Hepatitis C Virus21 products
- Leukaemia3 products
- ONCOLOGY PRODUCTS29 products
- Rectal Cancer16 products
- Solid Tumor6 products
- Taskin50 products
- Anti-Diabetic6 products
- BEST SELLER16 products
- Bladder Cancer19 products
- Breast Cancer19 products
- Colon & Rectal Cancer12 products
- Colorectal Cancer10 products
- Diabetic12 products
- Endometrial Cancer13 products
- Hepatitis B Virus7 products
- Hepatitis C Virus9 products
- Ibrutinib4 products
- Kidney Cancer22 products
- Leukaemia12 products
- Liver Cancer22 products
- Lung Cancer24 products
- Lymphoma13 products
- Mantle Cell Lymphoma11 products
- Melanoma12 products
- Non-Hodgkin7 products
- ONCOLOGY18 products
- ONCOLOGY PRODUCTS41 products
- Tumor2 products
CRIZONIX 250 MG
Crizonix Capsule 250 mg Indications Crizotinib is a kinase inhibitor indicated for the treatment of patients with- Metastatic non-small cell lung
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
LAPANIX 250 MG
LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase
LARONIB 25 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LENVANIX 10 MG
Lenvanix (lenvatinib) 10 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
REGONIX 40 MG
Product Description: Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis,
